Rohit Thapliyal
Rohit Thapliyal
Send Message
Rohit Thapliyal
Stop FollowingRohit Thapliyal
View as an RSS Feed
- A Closer Look At Lear: Many Reasons To Be Long And Short
- A Side-By-Side Comparison Of Star Scientific And ChromaDex
- Analyzing Lear Corporation's Expected Sales Figures
- Opko Health: Shorts Likely To Get Frostbite
- FDA Obesity Drug Decisions On June 27 And July 17 Will Affect These Stocks
- 4 Stock Pairs Worth Watching This Week
- Opko Health: CEO Buybacks Are Just The Beginning
